Global Stem Cell Therapy Market

Stem Cell Therapy Market Size, Share, Growth Analysis, By Type (Autologous, and Allogenic), By Therapeutic Application (Regenerative Medicine, Drug Discovery), By Cell source (Adipose tissue derived MSCS, Placental cord-derived MSCS), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2162 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 93 | Figures: 76

Stem Cell Therapy Market Insights

Global Stem Cell Therapy Market size was valued at USD 12.11 Billion in 2022 poised to grow from USD 13.33 Billion in 2023 to USD 28.79 Billion by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031). 

Stem cells are the body's source of raw materials, and other cells in the body that have different functions develop from them. Regenerative medicine is also known as stem cell therapy, which is the use of stem cells or cells derived from them to improve the natural healing process of damaged, dysfunctional or diseased tissue in an organism. It is the next stage of organ transplantation, using cells rather than the few donor organs. In a lab, researchers cultivate stem cells. These stem cells are modified to become different kinds of cells, like blood, neurone, or heart muscle cells. The rise of the global stem cell therapy market is also significantly aided by the rising incidence of diseases like cancer and the introduction of new products related to the treatment. 

The cells may also be inserted into an individual. The cells might be injected into the heart muscle, for example, if the patient has cardiac problems. After transplantation, the healthy heart muscle cells may help heal the damaged heart muscle. During the stem cell transplant procedure, the donor's immune system fights blood-related disorders and cancers such as leukemia, lymphoma, neuroblastoma, and multiple myeloma, or the damaged cells are replaced with the stem cells by chemotherapy. Umbilical cord blood or adult stem cells are used in these transplants. Stem cell therapy presents market potential due to the increase in induced pluripotent stem cells in embryonic stem cell therapy.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Stem Cell Therapy Market size was valued at USD 12.11 Billion in 2022 poised to grow from USD 13.33 Billion in 2023 to USD 28.79 Billion by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031). 

The global stem cell therapy market is extremely competitive worldwide, with major competitors spearheading research and growth. The global firms like Mesoblast Limited, Athersys, Inc., and Novartis AG have strong R&D pipelines and advanced stem cell drugs. They focus on clinical trials, launches of new products or strategic partnerships as a way of maintaining their competitive edge. Biotech companies are increasingly collaborating with academic institutions in the market to fast track the development of novel therapeutics. 'Mesoblast Limited (Australia) ', 'Athersys, Inc. (USA) ', 'Novartis AG (Switzerland) ', 'Osiris Therapeutics, Inc. (USA) ', 'StemCell Technologies Inc. (Canada) ', 'JCR Pharmaceuticals Co., Ltd. (Japan) ', 'Anterogen Co., Ltd. (South Korea) ', 'BrainStorm Cell Therapeutics Inc. (USA) ', 'Takeda Pharmaceutical Company Limited (Japan) ', 'Pharmicell Co., Ltd. (South Korea) ', 'Cellular Dynamics International, Inc. (USA) ', 'Vericel Corporation (USA) ', 'Holostem Terapie Avanzate S.r.l. (Italy) ', 'Gamida Cell Ltd. (Israel) ', 'BioTime, Inc. (USA)'

Financial assistance from governmental organizations and appropriate regulatory frameworks promotes a conducive atmosphere for stem cell therapy research and development. Increased research efforts and availability of funding for cell-based studies have generally arisen from the need for better and more creative treatment options for autoimmune, neurological, and cardiovascular diseases. 

Drug Companies Seek Specialized Talent Amidst Innovation in Therapeutics: As pharmaceutical companies are working on more intricate therapeutic areas and innovative drug delivery systems; they are looking for personnel having experience in the development of new products than at any other time. Increasingly, firms are exporting to companies with a rich history in unique areas like biology and controlled release formulations. 

North America leads the global stem cell therapy market due to its robust regulatory backing, significant investments in research and development as well as an elaborate healthcare network. This region also houses key biotech firms and scholarly bodies which stimulates advancement of stem cell technologies. Furthermore, a strong demand for cutting-edge medicines and the increasing frequency of chronic diseases fuel market expansion. The region's leadership is further strengthened by the financing for stem cell research and the supportive policies of the U.S. government. North America's market dominance is further attributed to the existence of significant market players and a firmly structured clinical trial infrastructure. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Stem Cell Therapy Market

Report ID: SQMIG35H2162

$5,300
BUY NOW GET FREE SAMPLE